Addex Increases Issued Share Capital and Creates Treasury Shares

Geneva, Switzerland, 31 May 2017 – Addex Therapeutics (ADXN.SW) announced today that it has increased its capital from 13,454,553 to 15`384`988 through the issue of 1,930,435 new registered shares at nominal value of CHF1 each to Addex Pharma S.A, its 100% subsidiary. The new shares were issued from the Company`s authorized share capital and are listed on the SIX Swiss Exchange. The transaction has been executed to provide the Group with additional treasury shares that can be used in the future to raise funds in an efficient manner.